Status:
COMPLETED
Post-occlusive Reactive Hyperemia and Basal-cell Carcinoma
Lead Sponsor:
Institut Curie
Conditions:
Carcinoma, Basal Cell
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators aim to test the hypothesis and to proof thank to laser speckle contrast imaging that post-occlusive reactive hyperemia (PORH) can be induced through a tumor, in this case, through a ...
Eligibility Criteria
Inclusion
- Age ≥ 18
- Histologically proved cutaneous BCC
- Patient being informed and having signed the consent to participate to the study
Exclusion
- Counter-indication to surgery
- Patient being unable to attend future follow-up visits
- Patient with severe cognitive impairment
- Patient not affiliated to a social security regimen
- Patient with limb BCC and history of peripheral vascular artery surgery like bypass and/or vascular prothesis on the same limb (tourniquet counter-indication)
- Local bone invasion of BCC detected with imagery
Key Trial Info
Start Date :
June 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2011
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01455363
Start Date
June 1 2011
End Date
October 1 2011
Last Update
November 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institut Curie
Paris, France, 75005